Work

Clinical Benefit From Pemetrexed Before and After Crizotinib Exposure and From Crizotinib Before and After Pemetrexed Exposure in Patients With Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer

Year: 2013

Type: article

Study design: Observational Study

Source: Clinical Lung Cancer

DOI: 10.1016/j.cllc.2013.06.005

Authors: Eamon M. Berge, Xian Lu, Delee Maxson, Anna E. Barón, Shirish M. Gadgeel, Benjamin J. Solomon, Robert C. Doebele, Maria Varella-Garcia, D. Ross Camidge

Institutions: University of Colorado Anschutz, University of Colorado Denver, Colorado School of Public Health, Wayne State University, The Barbara Ann Karmanos Cancer Institute, Peter MacCallum Cancer Centre

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Awards: Paul Calabresi Award in Clinical Oncology Research, University of Colorado Cancer Center Support Grant

OpenAlex ID: W2052294822

FWCI: 3.25

Cites: 34

Cited by: 24

Related to: 10